Bridgewater Associates’s Axcelis ACLS Stock Holding History

Bridgewater Associates’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$773K	Buy	+8,301	New	+$735K	﹤0.01%	827
2025 Q4	–	Sell	-2,224	Closed	-$217K	–	1041
2025 Q3	$217K	Buy	+2,224	New	+$179K	﹤0.01%	998
2025 Q1	–	Sell	-13,678	Closed	-$956K	–	668
2024 Q4	$956K	Sell	13,678 -5,367	-28%	-$446K	﹤0.01%	512
2024 Q3	$2M	Sell	19,045 -10,448	-35%	-$1.22M	0.01%	506
2024 Q2	$4.19M	Buy	+29,493	New	+$3.4M	0.02%	388

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bridgewater Associates's ACLS Position: Q1 2026 in Review

Bridgewater Associates opened a new position in Axcelis (ACLS) in Q1 2026: 8,301 shares worth $773K. The stake represents ﹤0.01% of the portfolio and ranks #827 among its holdings. This is a return to the name: Bridgewater Associates previously reported a position in ACLS as recently as Q3 2025.

Bridgewater Associates first reported a position in ACLS in Q2 2024 and has held it in 5 quarters since. The position peaked at $4.19M in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

Bridgewater Associates held 8,301 shares of Axcelis worth $773K as of Q1 2026.
Axcelis was a new Bridgewater Associates position in Q1 2026.
Axcelis made up ﹤0.01% of Bridgewater Associates's portfolio in Q1 2026, its #827 holding.
Bridgewater Associates first reported a position in Axcelis in Q2 2024 and has held it in 5 quarters since.
Bridgewater Associates's Axcelis position peaked at $4.19M in Q2 2024.
377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.